Comparing oral ibandronate with and without vitamin D for osteoporosis treatment
Examination of Bone Metabolism and Bone Mineral Density in Primary and Secondary Osteoporosis Treated by Oral Ibandronate
PHASE2 · Shinshu University · NCT03186131
This study tests if taking oral ibandronate for osteoporosis works better when combined with vitamin D compared to taking it alone.
Quick facts
| Phase | PHASE2 |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Shinshu University (other) |
| Locations | 1 site (Matsumoto, Nagano) |
| Trial ID | NCT03186131 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the efficacy of oral ibandronate in treating osteoporosis, specifically comparing its effects when administered alone versus in combination with active vitamin D. The study aims to gather comparative data to determine if the addition of vitamin D enhances the treatment outcomes for patients with osteoporosis. Participants will be monitored for improvements in bone density and overall health. The trial is designed for patients who prefer oral medication for their osteoporosis management.
Who should consider this trial
Good fit: Ideal candidates for this study are osteoporotic patients who are interested in taking oral ibandronate.
Not a fit: Patients who are allergic to oral ibandronate or vitamin D, or those who have not taken oral ibandronate in the last two years may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients with osteoporosis.
How similar studies have performed: There is limited comparative data available on this specific combination, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Osteoporotic patients who want to take oral ibandronate Exclusion Criteria: * Patients who are allergic to oral ibandronate or vitamin D Patients who have not taken oral ibandronate for the last 2 years
Where this trial is running
Matsumoto, Nagano
- Yukio Nakamura — Matsumoto, Nagano, Japan (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Osteoporosis